scholarly article | Q13442814 |
P50 | author | Nathalie Rosenblatt | Q58811012 |
Tamara Zehnder | Q86112363 | ||
P2093 | author name string | Lucas Liaudet | |
Feng Li | |||
Tetsuo Kunieda | |||
Chizuru Sogawa | |||
Bernard Waeber | |||
François Feihl | |||
Stéphanie Rignault-Clerc | |||
Christelle Bielmann | |||
P2860 | cites work | Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis | Q43272295 |
B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart | Q46981514 | ||
Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats | Q47318428 | ||
Heart failure: a state of brain natriuretic peptide deficiency or resistance or both! | Q48248556 | ||
Subcutaneous B-type natriuretic peptide for treatment of heart failure: a dying therapy reborn? | Q48309925 | ||
Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure | Q48495209 | ||
B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells | Q48710431 | ||
Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children | Q48865786 | ||
Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1. | Q53216215 | ||
Dedifferentiation and Proliferation of Mammalian Cardiomyocytes | Q27320581 | ||
Effect of nesiritide in patients with acute decompensated heart failure | Q28242547 | ||
Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury | Q28252995 | ||
A global double-fluorescent Cre reporter mouse | Q29616157 | ||
Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarction | Q30433780 | ||
BNP signaling is crucial for embryonic stem cell proliferation | Q30862341 | ||
FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. | Q33842934 | ||
Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development | Q33950331 | ||
c-kit+ cells minimally contribute cardiomyocytes to the heart | Q34021586 | ||
CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart | Q34526136 | ||
Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo | Q34855009 | ||
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications | Q34906050 | ||
Cardiovascular remodelling in coronary artery disease and heart failure | Q35090566 | ||
Minireview: natriuretic peptides during development of the fetal heart and circulation | Q35127242 | ||
Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide | Q36564032 | ||
The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice | Q37241365 | ||
Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. | Q37287472 | ||
Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart | Q37293770 | ||
Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury | Q37298343 | ||
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study | Q37329716 | ||
Natriuretic peptides in cardiovascular diseases of fetus, infants and children | Q37370305 | ||
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development | Q37429352 | ||
Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. | Q37828258 | ||
Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: insights from the meta-analysis of 1,389 patients from 20 trials | Q38181927 | ||
Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats | Q38934765 | ||
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). | Q39405535 | ||
NPR-A regulates self-renewal and pluripotency of embryonic stem cells | Q39578469 | ||
BMP-2 and FGF-2 synergistically facilitate adoption of a cardiac phenotype in somatic bone marrow c-kit+/Sca-1+ stem cells | Q40317182 | ||
B Type natriuretic peptide: a good omen in myocardial ischaemia? | Q43014687 | ||
Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation | Q43116126 | ||
B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter | Q43165127 | ||
P433 | issue | 1 | |
P304 | page(s) | 455 | |
P577 | publication date | 2014-12-02 | |
P1433 | published in | Basic Research in Cardiology | Q2453360 |
P1476 | title | Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth | |
P478 | volume | 110 |
Q30847428 | Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway |
Q92860231 | Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling |
Q54979872 | Characterizing the role of atrial natriuretic peptide signaling in the development of embryonic ventricular conduction system. |
Q99576092 | Crosstalk between cardiomyocytes and noncardiomyocytes is essential to prevent cardiomyocyte apoptosis induced by proteasome inhibition |
Q90720028 | Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration |
Q37633335 | Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1. |
Q26765883 | Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? |
Q48215945 | SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart. |
Q61807366 | Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations |
Q47855200 | Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure |
Search more.